What SkinPen is and how it works
SkinPen is an FDA-cleared mechanical microneedling system made by Bellus Medical, LLC, and marketed under the Crown Aesthetics brand. A motorized handpiece drives a sterile, single-use needle cartridge in rapid vertical oscillation, creating controlled micro-channels in the skin to prompt a wound-healing response. It works with needles alone: there is no radiofrequency, no thermal energy, and no ultrasound. Needle depth is set mechanically by the operator. The original device was authorized through the FDA De Novo pathway in 2018, which created the regulatory category it now occupies.
Mechanical microneedling drives fine needles to a set depth to create thousands of microscopic channels in the skin. The controlled micro-injury is associated with a remodeling response that clinics use for skin texture, fine lines, tone, and the appearance of scarring. The FDA-cleared indication is narrower than that range of uses: it covers improving the appearance of facial acne scars in adults aged 22 or older. Other applications, and suitability for any individual patient, are clinical decisions for the treating practitioner rather than properties of the device. Because SkinPen relies on mechanical injury rather than added energy, its downtime and cost profile differ from radiofrequency systems that heat the dermis. The manufacturer positions the device for use across skin types, with the practitioner setting depth and technique to the indication and the patient in front of them.
SkinPen Precision and Precision Elite
SkinPen is sold in two generations. The original SkinPen Precision was authorized in 2018. SkinPen Precision Elite reached the U.S. market in December 2024 as the current flagship. Both are motorized handpieces that the FDA Global Unique Device Identification Database (GUDID) records as reusable and serial-number tracked, paired with a disposable cartridge. According to the manufacturer, the Elite adds a redesigned cartridge unit, a digital display, and a rechargeable battery with inductive charging. The two generations use different cartridge units, so cartridges are not interchangeable between them.
For a clinic, the generation question is mostly a procurement and stock question: which handpiece is in service, which cartridge it accepts, and whether a unit offered for sale is the device it claims to be. Those checks, including how to confirm a unit against its FDA record before purchase, are covered in the guide to SkinPen Precision and Elite devices. SkinPen should also not be confused with MicroPen EVO, a separate Crown Aesthetics microneedling line rather than a SkinPen generation.
How SkinPen is regulated by the FDA
SkinPen Precision is FDA cleared. The words “cleared” and “approved” are not interchangeable: approval applies to Class III devices that go through premarket approval, while microneedling pens of this type are Class II. The FDA authorized the original SkinPen through a De Novo request (DEN160029) with a decision date of March 1, 2018. A De Novo grant is used when no comparable device already exists, so it created a new classification rather than clearing the device against an earlier predicate.
That classification is "powered microneedle device," product code QAI, under 21 CFR 878.4430. The FDA defines the category as a device that uses one or more needles to mechanically puncture and injure skin tissue for aesthetic use, which is a precise description of how SkinPen works. Because the De Novo established the category, SkinPen was the first microneedling device authorized by the FDA in it. For a buyer, this matters in two ways: it explains why some marketing still uses the word “approved” loosely for microneedling pens, and it gives a concrete record (a De Novo number and a product code) to check a device against. The full breakdown, including the cleared-versus-approved distinction, sits in the article on whether is SkinPen FDA cleared.
Cartridges, BioSheath, and consumables
Each treatment uses a single-use cartridge that mounts on the reusable handpiece. The FDA GUDID record for the SkinPen Precision cartridge lists it as single-use, sterilized with ethylene oxide, and lot tracked, while the handpiece is recorded as reusable and serial tracked. That split matters for a clinic: the consumable is disposed and reordered, the handpiece is kept and verified. The manufacturer specifies a 14-needle stainless-steel configuration and an adjustable depth range of 0.25 to 2.5 mm; those figures come from manufacturer documentation rather than the De Novo record, so clinics should treat them as manufacturer specifications and confirm against the current instructions for use.
The system also uses the BioSheath, described by the manufacturer as a single-use barrier that limits cross-contamination of the handpiece between uses. It is presented as a contamination barrier rather than a sterile field, and the manufacturer treats it as part of the cleared protocol. A fuller breakdown of how the single-use cartridge and BioSheath work covers sterilization, needle configuration, and generation compatibility in detail.
Cartridges are the recurring consumable in a SkinPen practice, so sourcing and compatibility drive running costs. Pinova carries professionally sourced SkinPen consumables; compatibility is based on industry-standard usage and clinical experience, and clinics should verify any cartridge against their specific handpiece and generation before ordering. Current stock is listed under SkinPen cartridges and treatment consumables.
Mechanical microneedling versus RF microneedling
The clearest way to place SkinPen is against radiofrequency microneedling. RF systems such as Morpheus8 use needles to deliver radiofrequency energy into the dermis, adding controlled heat to the mechanical injury and reaching more profound tissue effects that clinics associate with laxity and contour work. SkinPen does neither: it is mechanical only, with no energy delivered through the needles. That makes it a different tool with a different downtime and cost profile, not a weaker version of an RF device. The two even sit in different FDA classifications, which is a useful tell when reading a device's paperwork.
| Dimension | SkinPen (mechanical) | RF microneedling (e.g. Morpheus8) |
|---|---|---|
| Energy through needles | None | Radiofrequency (heat) |
| Primary mechanism | Mechanical micro-injury | Micro-injury plus dermal heating |
| Depth driver | Mechanical setting | Mechanical setting plus energy |
| FDA classification | 21 CFR 878.4430, code QAI | 21 CFR 878.4400, code GEI |
| Main consumable | Single-use needle cartridge | Single-use needle tip |
Clinics that run both choose between them by indication rather than ranking one above the other. The trade-offs, including where each fits and how SkinPen compares to other microneedling pens, are set out in the comparison of how mechanical microneedling compares to RF, and the category overview of RF microneedling devices gives the energy-based side of the picture.
Frequently asked questions
Is SkinPen FDA cleared, and is "approved" the right word?
SkinPen is FDA cleared. It was authorized through the De Novo pathway (DEN160029) in 2018. The word "approved" is not accurate for this device class: approval applies to Class III devices, and SkinPen is Class II.
Is SkinPen RF microneedling?
No. SkinPen performs mechanical microneedling using needles only, with no radiofrequency, thermal energy, or ultrasound. RF microneedling devices are a separate category that adds radiofrequency energy through the needles.
Who makes SkinPen?
The legal manufacturer of record in FDA filings is Bellus Medical, LLC, and the device is marketed under the Crown Aesthetics brand.
What is the difference between SkinPen Precision and Precision Elite?
Precision is the original 2018 device. Precision Elite, launched in the U.S. in late 2024, is the current generation and, per the manufacturer, adds a redesigned cartridge unit, a digital display, and inductive charging. The two use different cartridge units and are not cross-compatible.
